FINTECH
Search documents
Ocugen: A Retinal Disease Juggernaut In The Making
Seeking Alpha· 2025-09-23 15:11
Group 1 - The author, Sean Daly, specializes in ETFs, biotech, and FINTECH solutions within the banking sector [1] - He has a strong academic background, having taught international finance and financial risk management at Pace University and served as a visiting lecturer at Princeton University [1] - Daly's research interests include diverse topics such as Chinese urbanization, multilateral currency swap arrangements, energy geopolitics, and Asia's sovereign wealth funds [1] Group 2 - The author has a beneficial long position in the shares of OCGN, indicating a personal investment interest [2] - The article reflects the author's own opinions and is not influenced by compensation from any company mentioned [2]
METW: Harvesting Meta's Mag 7 Momo On A Weekly Basis
Seeking Alpha· 2025-07-29 10:14
Group 1 - The article discusses the expertise of Sean Daly in ETFs, biotech, and FINTECH solutions within the banking sector, highlighting his academic background and extensive writing on various economic topics [1] - Sean Daly has a global strategy and private equity background, focusing on long/short and event-driven equity approaches, particularly in small-cap biotech and emerging markets [1] Group 2 - There are no disclosures related to stock positions or business relationships with companies mentioned in the article [2] - The article emphasizes that past performance does not guarantee future results and does not provide specific investment recommendations [3]